Le Lézard
Classified in: Science and technology, Business
Subject: CON

OTC Markets Group Welcomes Cognosec AB to OTCQX


NEW YORK, March 19, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Cognosec AB (Nasdaq First North: COGS; OTCQX: CYBNY), a leading supplier of cyber security solutions with operations in Europe, Africa and the Middle East, has qualified to trade on the OTCQX® Best Market. 

Cognosec begins trading today on OTCQX under the symbol "CYBNY," where each ADR represents 10 ordinary shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"We are pleased to welcome Cognosec to the OTCQX Best Market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Trading on the OTCQX market will enable Cognosec to expand its shareholder base and visibility in the U.S. and to help grow liquidity in its home market."

"Cognosec is delighted to have been accepted on the OTCQX Best Market. Creating further exposure to U.S investors is of key strategic importance and we express our thanks to OTC Markets Group for facilitating this process," said Daniel Holden, Chief Financial Officer for Cognosec.

Cognosec was sponsored for OTCQX by J.P. Galda & Co., a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership. 

About Cognosec AB
Cognosec AB (Publ) is engaged in providing cyber resilience solutions and preventing cyber-attacks. The business conducts international operations from offices in Sweden, South Africa, the UK, Kenya, Germany, Austria and the United Arab Emirates. Listed on Nasdaq First North (Nasdaq:COGS) and traded on the OTCQX Best Market as CYBNY under a Level 1 ADR program, Cognosec delivers services and bespoke technologies to enhance public and private sector organizations' protections against unwanted intrusions and designs holistic, organisation-wide solutions to prevent diverse and increasing forms of information and identity theft.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, [email protected]

OTC Markets Group logo. (PRNewsFoto/OTC Markets Group)

 

SOURCE OTC Markets Group Inc.


These press releases may also interest you

at 23:16
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

at 23:05
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

at 23:03
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: